Stock comparison
LeMaitre Vascular
Sotera Health
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
SHC
Sotera Health
Market cap
$4.35B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | SHC | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 51C | LMAT |
| Benjamin Graham | 81A | 78B | LMAT |
| Philip Fisher | 73B | 47D | LMAT |
| Peter Lynch | 59C | 30F | LMAT |
| Joel Greenblatt | 48D | 24F | LMAT |
| Charlie Munger | 60C | 54C | LMAT |
| Terry Smith | 61C | 52C | LMAT |
Side-by-side metrics
| Metric | LMAT | SHC |
|---|---|---|
| Market cap | $2.32B | $4.35B |
| P/E (TTM) | 37.1x | 36.9x |
| EV/EBIT | 36.6x | 16.1x |
| ROIC (TTM) | 9.43% | 7.96% |
| Gross margin | 72.39% | 55.01% |
| Net margin | 24.35% | 9.91% |
| Revenue CAGR 5y | 12.75% | 5.72% |
| EPS CAGR 5y | 19.04% | -9.92% |
| Debt / Equity | 0.5x | 3.6x |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- EPS CAGR 5y19.04%vs -9.92%+152%
- Dividend yield0.84%vs 0.0%+100%
- Debt / Equity0.5xvs 3.6x+87%
- Net margin24.35%vs 9.91%+59%
SHC leads on
- EV/EBIT16.1xvs 36.6x+56%
- Market cap$4.35Bvs $2.32B+47%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.